193 related articles for article (PubMed ID: 6669662)
1. [Effect of amitriptyline on the activity of enzymes participating in biogenic amine metabolism in patients with affective disorders].
Matsumoto H; Pietruszewska I; Marcjan K
Psychiatr Pol; 1983; 17(5-6):417-20. PubMed ID: 6669662
[No Abstract] [Full Text] [Related]
2. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. III. Dopamine beta-hydroxylase (DBH) activity in the serum].
Matsumoto H; Pacyna M; Pietruszewska I; Lewicka-Wysocka H
Psychiatr Pol; 1983; 17(1):19-23. PubMed ID: 6622589
[No Abstract] [Full Text] [Related]
3. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
Anokhina IP; Gamaleia NB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209
[No Abstract] [Full Text] [Related]
4. [Current biochemical conceptions of mental disorders. I. Biogenic amines in the pathogenesis of schizophrenia].
Anokhina IP; Gamaleia NB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1096-1105. PubMed ID: 384732
[No Abstract] [Full Text] [Related]
5. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. II. Catechol-O-methyltransferase (COMT) activity in the soluble erythrocyte fraction].
Matsumoto H; Stencka K; Pietruszewska I; Marcjan K
Psychiatr Pol; 1983; 17(1):13-8. PubMed ID: 6622588
[No Abstract] [Full Text] [Related]
6. Neurotransmitter-related enzymes in the major psychiatric disorders: I. Catechol-O-methyl transferase, monoamine oxidase in the affective disorders, and factors affecting some behaviorally correlated enzyme activities.
Murphy DL; Wyatt RJ
Res Publ Assoc Res Nerv Ment Dis; 1975; 54():277-88. PubMed ID: 769115
[No Abstract] [Full Text] [Related]
7. Effect of trimipramine, an atypical tricyclic antidepressant, on the activities of various enzymes involved in the metabolism of biogenic amines.
Yu PH; Boulton AA
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):409-16. PubMed ID: 1972801
[TBL] [Abstract][Full Text] [Related]
8. [Effect of hospitalization on the activity of enzymes of biogenic amine metabolism and on the mood of healthy volunteers].
Matsumoto H; Pietruszewska I; Stencka K; Pacyna M; Lewicka-Wysocka H; Roguska E
Pol Tyg Lek; 1982 Jul; 37(23):675-7. PubMed ID: 7177961
[No Abstract] [Full Text] [Related]
9. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. I. Platelet monoamine oxidase (MAO) activity].
Matsumoto H; Pietruszewska I; Roguska E
Psychiatr Pol; 1983; 17(1):7-11. PubMed ID: 6622594
[No Abstract] [Full Text] [Related]
10. Molecular geometry and adrenergic drug activity.
Patil PN; Miller DD; Trendelenburg U
Pharmacol Rev; 1974 Dec; 26(4):323-92. PubMed ID: 4156804
[No Abstract] [Full Text] [Related]
11. Biogenic amines and affective disorders.
Schildkraut JJ
Annu Rev Med; 1974; 25(0):333-48. PubMed ID: 4368455
[No Abstract] [Full Text] [Related]
12. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. II. Erythrocyte catechol-O-methyltransferase activity in endogenous depression.
Puzynski S; Bidzinski A; Mrozek S; Zaluska M
Acta Psychiatr Scand; 1983 Feb; 67(2):96-100. PubMed ID: 6846043
[TBL] [Abstract][Full Text] [Related]
13. [Significance of various enzymes of mediator metabolism for evaluation of depression and therapeutic prognosis].
Vertogradova OP; Misionzhinik EIu; Poliakov SE; Uzbekov MG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(1):99-103. PubMed ID: 1319664
[TBL] [Abstract][Full Text] [Related]
14. [Monoamine and monoamine enzyme abnormalities in childhood autism].
Garnier C; Barthelemy C; Garreau B; Jouve J; Muh JP; Lelord G
Encephale; 1983; 9(3):201-62. PubMed ID: 6317336
[TBL] [Abstract][Full Text] [Related]
15. [Correlations between the EEG pattern of sleep and depressive syndrome in patients with bipolar affective disorders before and during treatment with amitriptyline].
Ekiert H; Gogol Z; Jernajczyk W
Psychiatr Pol; 1983; 17(4):287-93. PubMed ID: 6657811
[No Abstract] [Full Text] [Related]
16. The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment.
Schildkraut JJ
Psychopharmacol Bull; 1974 Jan; 10(1):5-25. PubMed ID: 4590871
[No Abstract] [Full Text] [Related]
17. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. III. Platelet monoamine oxidase activity in endogenous depression.
Puzynski S; Hauptmann M; Zaluska M
Acta Psychiatr Scand; 1983 Feb; 67(2):101-8. PubMed ID: 6846038
[TBL] [Abstract][Full Text] [Related]
18. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. I. Plasma dopamine-beta-hydroxylase activity in endogenous depression.
Puzynski S; Rode A; Zaluska M
Acta Psychiatr Scand; 1983 Feb; 67(2):89-95. PubMed ID: 6846042
[TBL] [Abstract][Full Text] [Related]
19. [Modern achievements in the field of catecholamine biochemistry].
Gorkin VZ
Vopr Med Khim; 1974 May; 20(3):227-38. PubMed ID: 4152064
[No Abstract] [Full Text] [Related]
20. [Modifications of cerebral amine metabolism in psychiatric illness].
Linkowski P; Mendlewicz J
Acta Psychiatr Belg; 1980; 80(5):559-73. PubMed ID: 6165224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
